Literature DB >> 31597639

Temporal Analysis of Amylase Expression in Control, Autoantibody-Positive, and Type 1 Diabetes Pancreatic Tissues.

Irina Kusmartseva1, Maria Beery1, Helmut Hiller1, Myriam Padilla1, Stephen Selman1, Amanda Posgai1, Harry S Nick2, Martha Campbell-Thompson1, Desmond A Schatz3, Michael J Haller3, Clive H Wasserfall1, Mark A Atkinson4,3.   

Abstract

Within the human pancreas, exocrine and endocrine cells control secretion of digestive enzymes and production of hormones to maintain metabolic homeostasis, respectively. While the vast majority of type 1 diabetes research efforts have focused on endocrine function and autoimmunity, recent studies identified a series of unique features (e.g., reduced weight and volume, increased density of leukocytes) within the exocrine pancreas in this disease, but the mechanisms underlying these aberrancies are unknown. Therefore, we histologically assessed amylase, insulin, glucagon, lipase, and/or trypsinogen in 78 organ donor pancreata from birth through adulthood in control subjects and those at various stages of type 1 diabetes. While amylase-positive (AMY+) acinar cells were detectable in pancreata from all study groups, tissues from individuals >2 years of age contained clusters of acinar cells devoid of amylase (AMY-). A majority of these AMY- cell clusters localized proximal to islets (i.e., peri-islet). Additionally, most AMY- clusters were positive for the exocrine enzymes lipase and trypsinogen. Interestingly, type 1 diabetes pancreata displayed significant reductions in the frequency of these AMY- cell clusters. These results support a contribution of the islet-acinar axis in pancreatic development and underscore a potential role for the exocrine pancreas in the pathogenesis of type 1 diabetes.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31597639      PMCID: PMC6925584          DOI: 10.2337/db19-0554

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

1.  Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes.

Authors:  Martha Campbell-Thompson; Clive Wasserfall; Emily L Montgomery; Mark A Atkinson; John S Kaddis
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272

2.  Pancreatic islet-acinar cell interaction: amylase messenger RNA levels ar determined by insulin.

Authors:  M Korc; D Owerbach; C Quinto; W J Rutter
Journal:  Science       Date:  1981-07-17       Impact factor: 47.728

3.  Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes.

Authors:  Martha L Campbell-Thompson; Stephanie L Filipp; Joseph R Grajo; Bimota Nambam; Richard Beegle; Erik H Middlebrooks; Matthew J Gurka; Mark A Atkinson; Desmond A Schatz; Michael J Haller
Journal:  Diabetes Care       Date:  2018-12-14       Impact factor: 19.112

4.  The influence of type 1 diabetes on pancreatic weight.

Authors:  Martha L Campbell-Thompson; John S Kaddis; Clive Wasserfall; Michael J Haller; Alberto Pugliese; Desmond A Schatz; Jonathan J Shuster; Mark A Atkinson
Journal:  Diabetologia       Date:  2015-09-10       Impact factor: 10.122

Review 5.  Structure and function of the exocrine pancreas in patients with type 1 diabetes.

Authors:  Laure Alexandre-Heymann; Roberto Mallone; Christian Boitard; Raphaël Scharfmann; Etienne Larger
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

Review 6.  ESPEN guideline: Clinical nutrition in surgery.

Authors:  Arved Weimann; Marco Braga; Franco Carli; Takashi Higashiguchi; Martin Hübner; Stanislaw Klek; Alessandro Laviano; Olle Ljungqvist; Dileep N Lobo; Robert Martindale; Dan L Waitzberg; Stephan C Bischoff; Pierre Singer
Journal:  Clin Nutr       Date:  2017-03-07       Impact factor: 7.324

7.  Galanin inhibits caerulein-stimulated pancreatic amylase secretion via cholinergic nerves and insulin.

Authors:  Savio G Barreto; Charmaine M Woods; Colin J Carati; Ann C Schloithe; Surendra R Jaya; James Toouli; Gino T P Saccone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-04       Impact factor: 4.052

8.  Pancreatic digestive enzyme secretion in the rabbit: rapid cyclic variations in enzyme composition.

Authors:  J W Adelson; R Clarizio; J A Coutu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes.

Authors:  Teresa Rodriguez-Calvo; Olov Ekwall; Natalie Amirian; Jose Zapardiel-Gonzalo; Matthias G von Herrath
Journal:  Diabetes       Date:  2014-06-19       Impact factor: 9.461

Review 10.  The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings.

Authors:  Alberto Pugliese; Mingder Yang; Irina Kusmarteva; Tiffany Heiple; Francesco Vendrame; Clive Wasserfall; Patrick Rowe; Jayne M Moraski; Suzanne Ball; Les Jebson; Desmond A Schatz; Roberto Gianani; George W Burke; Concepcion Nierras; Teo Staeva; John S Kaddis; Martha Campbell-Thompson; Mark A Atkinson
Journal:  Pediatr Diabetes       Date:  2013-12-10       Impact factor: 4.866

View more
  9 in total

Review 1.  The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes.

Authors:  Alessandra Petrelli; Sarah K Popp; Riho Fukuda; Christopher R Parish; Emanuele Bosi; Charmaine J Simeonovic
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

2.  Localization of enteroviral RNA within the pancreas in donors with T1D and T1D-associated autoantibodies.

Authors:  Shirin Geravandi; Sarah Richardson; Alberto Pugliese; Kathrin Maedler
Journal:  Cell Rep Med       Date:  2021-08-17

3.  Image-Based Machine Learning Algorithms for Disease Characterization in the Human Type 1 Diabetes Pancreas.

Authors:  Xiaohan Tang; Irina Kusmartseva; Shweta Kulkarni; Amanda Posgai; Stephan Speier; Desmond A Schatz; Michael J Haller; Martha Campbell-Thompson; Clive H Wasserfall; Bart O Roep; John S Kaddis; Mark A Atkinson
Journal:  Am J Pathol       Date:  2020-12-08       Impact factor: 4.307

4.  Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size.

Authors:  James J Ross; Clive H Wasserfall; Rhonda Bacher; Daniel J Perry; Kieran McGrail; Amanda L Posgai; Xiaoru Dong; Andrew Muir; Xia Li; Martha Campbell-Thompson; Todd M Brusko; Desmond A Schatz; Michael J Haller; Mark A Atkinson
Journal:  Diabetes       Date:  2021-01-13       Impact factor: 9.461

5.  Impaired exocrine pancreatic function in different stages of type 1 diabetes.

Authors:  Manuela Battaglia; Emanuele Bosi; Nicoletta Dozio; Rita Indirli; Gian Maria Giamporcaro; Laura Frosio; Alessandra Mandelli; Andrea Laurenzi; Andrea Mario Bolla; Angela Stabilini; Andrea Valle; Massimo Locatelli; Giulia Martina Cavestro; Marina Scavini
Journal:  BMJ Open Diabetes Res Care       Date:  2021-02

Review 6.  Quantitative Magnetic Resonance Imaging of the Pancreas of Individuals With Diabetes.

Authors:  John Virostko
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-04       Impact factor: 5.555

7.  Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies.

Authors:  Brittany S Bruggeman; Martha Campbell-Thompson; Stephanie L Filipp; Matthew J Gurka; Mark A Atkinson; Desmond A Schatz; Laura M Jacobsen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-29       Impact factor: 6.055

Review 8.  Exocrine Pancreas Dysfunction in Type 1 Diabetes.

Authors:  Timothy P Foster; Brittany Bruggeman; Martha Campbell-Thompson; Mark A Atkinson; Michael J Haller; Desmond A Schatz
Journal:  Endocr Pract       Date:  2020-12       Impact factor: 3.443

Review 9.  Presumption of guilt for T cells in type 1 diabetes: lead culprits or partners in crime depending on age of onset?

Authors:  Alexia Carré; Sarah J Richardson; Etienne Larger; Roberto Mallone
Journal:  Diabetologia       Date:  2020-10-21       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.